Tuberculosis: Past, Present and Future

被引:0
|
作者
Moghaddam, Habibolah Taghizade [1 ]
Moghadam, Zahra Emami
Khademi, Gholamreza [2 ]
Bahreini, Abbas [3 ]
Saeidi, Masumeh [4 ]
机构
[1] Mashhad Univ Med Sci, Dept Biochem, Mashhad, Iran
[2] Mashhad Univ Med Sci, Dept Pediat, Fac Med, Mashhad, Iran
[3] Shiraz Univ Med Sci, Students Res Comm, Fac Med, Shiraz, Iran
[4] Mashhad Univ Med Sci, Students Res Comm, Fac Med, Mashhad, Iran
来源
关键词
Children; HIV/AIDS; Prevalence; Tuberculosis;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Tuberculosis (TB) is the second-most common cause of death from infectious disease (after those due to HIV/AIDS). Roughly one-third of the world's population has been infected with M. tuberculosis, with new infections occurring in about 1% of the population each year. People with active TB can infect 10-15 other people through close contact over the course of a year. Materials and Methods The current study is a review survey which was conducted to evaluate of current status of TB prevalence by studying WHO website, Centers for Disease Control and Prevention (CDC), United Nations Children's Fund (UNICEF) and United Nations (UN) websites. Results In 2014, 9.6 million people fell ill with TB and 1.5 million (1.1 million HIV-negative and 0.4 million HIV-positive) died from the disease. Over 95% of TB deaths occur in low-and middle-income countries, and it is among the top 5 causes of death for women aged 15 to 44. One million children (014 years) fell ill with TB, and 140 000 children died from the disease in 2014; also, about 80% of reported TB cases occurred in 22 countries. The 6 countries that stand out as having the largest number of incident cases in 2014 were: India, Indonesia, Nigeria, Pakistan, People's Republic of China and South Africa. The TB death rate dropped 47% between 1990 and 2015. Conclusion Despite the fact that nearly all patients can be cured, TB remains one of the world's biggest threats. Ending the TB epidemic by 2030 is among the health targets of the newly adopted Sustainable Development Goals.
引用
收藏
页码:1243 / 1254
页数:12
相关论文
共 50 条
  • [1] Tuberculosis: The Past, the Present and the Future
    Koegelenberg, Coenraad F. N.
    Schoch, Otto D.
    Lange, Christoph
    [J]. RESPIRATION, 2021, 100 (07) : 553 - 556
  • [2] TUBERCULOSIS, PAST, PRESENT AND FUTURE
    PASVOL, G
    [J]. JOURNAL OF INFECTION, 1993, 27 (01) : 5 - 10
  • [3] TUBERCULOSIS - PAST, PRESENT AND FUTURE
    PAINE, AL
    HERSHFIELD, ES
    [J]. CANADIAN FAMILY PHYSICIAN, 1979, 25 (JAN) : 55 - 58
  • [4] TUBERCULOSIS - PAST, PRESENT, FUTURE
    DESPIERRES, G
    [J]. LYON MEDICAL, 1976, 236 (17): : 509 - 513
  • [5] Tuberculosis therapy: past, present and future
    Iseman, MD
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 : 87S - 94S
  • [6] TUBERCULOSIS IN BELGIUM - PAST, PRESENT AND FUTURE
    GYSELEN, A
    [J]. ACTA CLINICA BELGICA, 1994, 49 (3-4): : 125 - 131
  • [7] Tuberculosis vaccines: past, present and future
    Martin, Carlos
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (03) : 186 - 191
  • [8] The chemotherapy of tuberculosis: past, present and future
    Mitchison, D.
    Davies, G.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (06) : 724 - 732
  • [9] GYNECOLOGICAL TUBERCULOSIS, PAST, PRESENT AND FUTURE
    SUTHERLAND, AM
    [J]. ARCHIV FUR GYNAKOLOGIE, 1975, 218 (04): : 261 - 268
  • [10] Tuberculosis assays: past, present and future
    Chegou, Novel N.
    Hoek, Kim G. P.
    Kriel, Magdalena
    Warren, Robin M.
    Victor, Thomas C.
    Walzl, Gerhard
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (04) : 457 - 469